The complex relation between obstructive sleep apnoea syndrome, hypogonadism and testosterone replacement therapy

The complex relation between obstructive sleep apnoea syndrome, hypogonadism and testosterone replacement therapy

Obstructive sleep apnoea syndrome (OSAS) is an under-recognized medical disease. The main risk factors for OSAS are male sex, older age, obesity, and metabolic syndrome, that are also associated with male hypogonadism (MH). Therefore, obesity has been classically identified as the most evident link...

Bibliografski detalji
Glavni autori:	Andrea Graziani, Giuseppe Grande, Alberto Ferlin
Format:	Članak
Jezik:	English
Izdano:	Frontiers Media S.A. 2023-10-01
Serija:	Frontiers in Reproductive Health
Teme:	OSAS hypogonadism testosterone testosterone replacement therapy obesity
Online pristup:	https://www.frontiersin.org/articles/10.3389/frph.2023.1219239/full

Slični predmeti

Management of Male Fertility in Hypogonadal Patients on Testosterone Replacement Therapy
od: Julius Fink, i dr.
Izdano: (2024-02-01)

Clinical and pharmacological basis of the use of testosterone drugs for hormonal replacement therapy for hypogonadism in men
od: N. I. Volkova, i dr.
Izdano: (2022-09-01)

Usefulness of routine assessment of free testosterone for the diagnosis of functional male hypogonadism
od: Paolo Facondo, i dr.
Izdano: (2022-12-01)

ASSESSING CARDIOVASCULAR SAFETY OF TESTOSTERONE REPLACEMENT THERAPY FOR MALE HYPOGONADISM: A SYSTEMATIC REVIEW AND META-ANALYSIS
od: Manarul Iman Alfafa Rachman, i dr.
Izdano: (2024-09-01)

Impact of testosterone levels and testosterone replacement ther-apy on men’s health
od: Zuzanna Karbowska, i dr.
Izdano: (2023-12-01)

Acquired Male Hypogonadism in the Post-Genomic Era—A Narrative Review
od: Giuseppe Grande, i dr.
Izdano: (2023-09-01)

Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men
Izdano: (2012-12-01)

Plasma metabolomics in male primary and functional hypogonadism
od: Giuseppe Grande, i dr.
Izdano: (2023-05-01)

Age-Related Male Hypogonadism and Cognitive Impairment in the Elderly: Focus on the Effects of Testosterone Replacement Therapy on Cognition
od: Giuseppe Lisco, i dr.
Izdano: (2020-10-01)

LATE ONSET HYPOGONADISM: TO TREAT, NOT TO TREAT AND WHO MUST TREAT?
od: Z. R. Gusova, i dr.
Izdano: (2016-03-01)

Testosterone replacement therapy and vascular thromboembolic events: a systematic review and meta-analysis
od: Rossella Cannarella, i dr.
Izdano: (2024-01-01)

Sleep disorders and testosterone deficiency in men
od: I. A. Khripun, i dr.
Izdano: (2025-01-01)

Evaluation of sexual functional status and consistency of scales in patients with hypogonadotropic hypogonadism before and after testosterone replacement therapy: a single-center experience
od: Umit Aydogan, i dr.
Izdano: (2023-01-01)

Application of Transdermal Testosterone in Treatment of Male Hypogonadism
od: Mahgol Tajbakhsh, i dr.
Izdano: (2018-10-01)

The association of hypogonadism with depression and its treatments
od: Rita Indirli, i dr.
Izdano: (2023-08-01)

Testosterone Replacement Therapy: Effects on Blood Pressure in Hypogonadal Men
od: Geoffrey Hackett, i dr.
Izdano: (2024-10-01)

Guidelines for the Diagnosis and Treatment of testosterone deficiency (hypogonadism) in male patients with diabetes mellitus
od: Ivan I. Dedov, i dr.
Izdano: (2017-12-01)

Novel perspectives of testosterone therapy in men with functional hypogonadism: traversing the gaps of knowledge
od: Kristina Groti Antonič, i dr.
Izdano: (2024-12-01)

The HEAT-Registry (HEmatopoietic Affection by Testosterone): comparison of a transdermal gel vs long-acting intramuscular testosterone undecanoate in hypogonadal men
od: Michael Zitzmann, i dr.
Izdano: (2022-12-01)

Testosterone replacement therapy in adolescents and young men
od: Alexandra Aponte Varnum, i dr.
Izdano: (2024-10-01)

Long-term testosterone replacement therapy reduces fatigue in men with hypogonadism
od: Maurício de Almeida Ferreira, i dr.
Izdano: (2022-02-01)

A National Analysis of Temporal Changes in Prescribing of Testosterone Replacement Therapy Considering Methods of Delivery and Government Regulation
od: Andrew Morton, i dr.
Izdano: (2021-01-01)

Safety Aspects and Rational Use of Testosterone Undecanoate in the Treatment of Testosterone Deficiency: Clinical Insights
od: Campbell K, i dr.
Izdano: (2023-03-01)

Syndrome of hypogonadism in males
Izdano: (2014-06-01)

Racial differences in hypogonadal improvement and prostate-specific antigen levels in hypogonadal men treated with testosterone replacement therapy
od: Robert M. Coward, i dr.
Izdano: (2010-12-01)

Testosterone Replacement Therapy in Adolescents With Sickle Cell Disease Reverses Hypogonadism Without Promoting Priapism: A Case Report
od: Belinda F. Morrison, i dr.
Izdano: (2015-11-01)

Osteoporosis and bone metabolism in patients with Klinefelter syndrome
od: Giuseppe Grande, i dr.
Izdano: (2023-07-01)

Testosterone and aging male, a perspective from a developing country
od: Bac Nguyen Hoai, i dr.
Izdano: (2023-12-01)

Testosterone treatment in the aging male: myth or reality?
od: Nicole Nigro, i dr.
Izdano: (2012-03-01)

Does Testosterone Salvage PDE5i Non-Responders? A Scoping Review
od: Mike Pignanelli, i dr.
Izdano: (2023-02-01)

Guidelines for the diagnosis and treatment of testosterone deficiency (hypogonadism) in male patients with diabetes mellitus (Draft)
od: Galina Afanas'evna Melnichenko, i dr.
Izdano: (2017-06-01)

Testosterone replacement therapy and the risk of adverse cardiovascular outcomes and mortality
od: Kevin M. Pantalone, i dr.
Izdano: (2019-03-01)

Secondary male hypogonadism: A prevalent but overlooked comorbidity of obesity
od: María Molina-Vega, i dr.
Izdano: (2018-01-01)

The role of anti-aging approaches in managing hypogonadism in sedentary older males
od: Khaled A. Abdel-Sater
Izdano: (2024-11-01)

Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men
Izdano: (2013-03-01)

High C-reactive protein is associated with increased risk of biochemical hypogonadism: a population-based cohort study
od: Amar Osmancevic, i dr.
Izdano: (2022-06-01)

Association of hypogonadism with the severity of chronic obstructive pulmonary disease
od: MA. Zohal, i dr.
Izdano: (2015-12-01)

The clinical and epidemiological characteristics of hypogonadism in men with type 2 diabetes mellitus
od: Galina A. Mel'nichenko, i dr.
Izdano: (2019-12-01)

The prevalence of hypogonadism in men with type 2 diabetes mellitus in clinical practice
od: Galina A. Melnichenko, i dr.
Izdano: (2019-06-01)

Clomiphene citrate treatment for late onset hypogonadism: rise and fall
od: Marcelo Marconi, i dr.